Correlation Between Revelation Biosciences and Genelux Common

Can any of the company-specific risk be diversified away by investing in both Revelation Biosciences and Genelux Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revelation Biosciences and Genelux Common into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Revelation Biosciences and Genelux Common, you can compare the effects of market volatilities on Revelation Biosciences and Genelux Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revelation Biosciences with a short position of Genelux Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revelation Biosciences and Genelux Common.

Diversification Opportunities for Revelation Biosciences and Genelux Common

0.57

Correlation Coefficient

Revelation Biosciences  Genelux Common

Very weak diversification

The 3 months correlation between Revelation and Genelux is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Revelation Biosciences and Genelux Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genelux Common and Revelation Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revelation Biosciences are associated (or correlated) with Genelux Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genelux Common has no effect on the direction of Revelation Biosciences i.e., Revelation Biosciences and Genelux Common go up and down completely randomly.

Pair Corralation between Revelation Biosciences and Genelux Common

Given the investment horizon of 90 days Revelation Biosciences is expected to under-perform the Genelux Common. In addition to that, Revelation Biosciences is 1.72 times more volatile than Genelux Common. It trades about -0.05 of its total potential returns per unit of risk. Genelux Common is currently generating about -0.06 per unit of volatility. If you would invest  1,264  in Genelux Common on October 10, 2024 and sell it today you would lose (1,009) from holding Genelux Common or give up 79.83% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Revelation Biosciences  vs.  Genelux Common

Revelation Biosciences

Risk-Adjusted Performance

0 of 100

Weak

Over the last 90 days Revelation Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Revelation Biosciences is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Genelux Common

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Genelux Common are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak essential indicators, Genelux Common may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Revelation Biosciences and Genelux Common

The main advantage of trading using opposite Revelation Biosciences and Genelux Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revelation Biosciences position performs unexpectedly, Genelux Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genelux Common will offset losses from the drop in Genelux Common's long position.

The idea behind Revelation Biosciences and Genelux Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.